{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:31:20Z","timestamp":1793503880158,"version":"4.5.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006292","name":"Infectious Diseases Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Respiratory viruses\u2014including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19), respiratory syncytial virus (RSV), and influenza\u2014pose significant risks to immunocompromised patients, who experience attenuated vaccine responses and higher morbidity. To address evolving vaccine recommendations for the 2025\u20132026 season, the Infectious Diseases Society of America (IDSA), in collaboration with the Vaccine Integrity Project (VIP) and partner organizations, developed rapid guidelines for US-licensed vaccines targeting these viruses. The guideline applies to adults and children with compromised immunity due to hematologic malignancy, solid organ or hematopoietic cell transplantation, autoimmune disease on immunosuppressants, human immunodeficienty virus with severe immunosuppression, and similar conditions. Strong recommendations, supported by moderate certainty evidence, endorse timely administration of age-appropriate COVID-19, RSV, and influenza vaccines, with guidance on optimal timing relative to immunosuppressive therapy and transplantation. Coadministration of these vaccines is considered appropriate. Research gaps remain in immunogenicity, durability, and clinical effectiveness, particularly for patients receiving B-cell\u2013depleting therapies or early post-transplant. Priority areas include defining correlates of protection, optimizing vaccine schedules, evaluating high-dose or adjuvanted formulations, and improving real-world effectiveness and safety data. Equity and access strategies are essential to ensure uptake among vulnerable populations. These guidelines aim to support evidence-based decision-making and highlight the need for harmonized, multi-virus research to inform tailored vaccination strategies for immunocompromised individuals.<\/jats:p>","DOI":"10.1093\/cid\/ciag114","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:55:36Z","timestamp":1772283336000},"page":"i105-i110","source":"Crossref","is-referenced-by-count":16,"title":["IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2489-2838","authenticated-orcid":false,"given":"Anoma","family":"Nellore","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, NYU Langone Health and the NYU Transplant Institute , NewYork, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8441-5737","authenticated-orcid":false,"given":"Paul","family":"Goepfert","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham Division of Infectious Diseases, Department of Medicine, , Birmingham, Alabama ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Sabrina","family":"Tan","sequence":"additional","affiliation":[{"name":"University of Iowa Division of Infectious Diseases, Department of Medicine, Carver College of Medicine, , Iowa city, Iowa ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Bajema","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University, Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Belden","sequence":"additional","affiliation":[{"name":"Thomas Jefferson University Division of Infectious Diseases and Environmental Medicine, , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Blumberg","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Disease, Department of Pediatrics, University of California Davis, School of Medicine, Sacramento,California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan J","family":"Katz","sequence":"additional","affiliation":[{"name":"The Johns Hopkins University Division of Infectious Diseases, Department of Medicine, , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kaul","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School Division of Infectious Diseases, Department of Internal Medicine, , Ann Arbor, Michigan ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3452-0666","authenticated-orcid":false,"given":"Tanvi","family":"Sharma","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital and Harvard Medical School Division of Infectious Diseases, , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7761-1163","authenticated-orcid":false,"given":"Shweta","family":"Anjan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Miami Miller School of Medicine and Miami Transplant Institute, Miami, Florida ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella J","family":"Ariza-Heredia","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center Division of Internal Medicine, Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Magana","sequence":"additional","affiliation":[{"name":"The Ohio State University Department of Internal Medicine, , Wexner Medical Center, Columbus, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Minniear","sequence":"additional","affiliation":[{"name":"University of Tennessee Health Science Center, Le Bonheur Children's Hospital Division of Pediatric Infectious Diseases, , Memphis, Tennessee ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Loveless","sequence":"additional","affiliation":[{"name":"Lovevidence LLC , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipleen","family":"Kaur","sequence":"additional","affiliation":[{"name":"Infectious Diseases Society of America Clinical Affairs and Practice Guidelines, , Arlington, Virginia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"York","sequence":"additional","affiliation":[{"name":"Infectious Diseases Society of America Clinical Affairs and Practice Guidelines, , Arlington, Virginia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yngve","family":"Falck-Ytter","sequence":"additional","affiliation":[{"name":"Case Western Reserve University, Cleveland VA Northeast Ohio Healthcare System, , Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Baden","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital and Harvard Medical School Division of Infectious Diseases, , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"2026082412171373700_ciag114-B1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1164\/rccm.201804-0681OC","article-title":"Clinical significance of upper airway virus detection in critically ill hematology patients","volume":"199","author":"Legoff","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026082412171373700_ciag114-B2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ccm.2022.11.012","article-title":"Coronavirus disease-2019 in the immunocompromised host","volume":"44","author":"Bertini","year":"2023","journal-title":"Clin Chest Med"},{"key":"2026082412171373700_ciag114-B3","doi-asserted-by":"crossref","first-page":"e00042-19","DOI":"10.1128\/CMR.00042-19","article-title":"Community-acquired respiratory viruses in transplant patients: diversity, impact, unmet clinical needs","volume":"32","author":"Ison","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"2026082412171373700_ciag114-B4","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/cid\/ciy1047","article-title":"Community-acquired respiratory viruses are a risk factor for chronic lung allograft dysfunction","volume":"69","author":"Peghin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026082412171373700_ciag114-B5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijid.2017.07.011","article-title":"Respiratory viruses in transplant recipients: more than just a cold. Clinical syndromes and infection prevention principles","volume":"62","author":"Abbas","year":"2017","journal-title":"Int J Infect Dis"},{"key":"2026082412171373700_ciag114-B6","doi-asserted-by":"crossref","first-page":"337.e1","DOI":"10.1016\/j.jtct.2022.03.010","article-title":"High mortality of COVID-19 early after allogeneic stem cell transplantation: a retrospective multicenter analysis on behalf of the German cooperative transplant study group","volume":"28","author":"Schaffrath","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2026082412171373700_ciag114-B7","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1038\/s41598-025-95246-w","article-title":"Nationwide study of COVID-19 outcomes in hematologic patients following bone marrow transplantation","volume":"15","author":"Garcia-Carretero","year":"2025","journal-title":"Sci Rep"},{"key":"2026082412171373700_ciag114-B8","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.3389\/fmicb.2018.03294","article-title":"Respiratory virus infections in hematopoietic cell transplant recipients","volume":"9","author":"Pochon","year":"2018","journal-title":"Front Microbiol"},{"key":"2026082412171373700_ciag114-B9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/cid\/cit725","article-title":"The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts","volume":"58","author":"Memoli","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026082412171373700_ciag114-B10","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/cid\/ciz638","article-title":"Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011\u20132015","volume":"70","author":"Collins","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026082412171373700_ciag114-B11","author":"Center for Infectious Disease Research and Policy"},{"issue":"22):","key":"2026082412171373700_ciag114-B12","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMsa2514268","article-title":"Updated evidence for COVID-19, RSV, and influenza vaccines for 2025\u20132026","volume":"393","author":"Scott","year":"2025","journal-title":"N Engl J Med"},{"key":"2026082412171373700_ciag114-B13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.15585\/mmwr.mm7337e2","article-title":"Use of COVID-19 vaccines for persons aged \u22656 months: recommendations of the advisory committee on immunization practices\u2014United States, 2024\u20132025","volume":"73","author":"Panagiotakopoulos","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026082412171373700_ciag114-B14","first-page":"1161","article-title":"Vaccination recommendations in solid organ transplant adult candidates and recipients","volume":"11","author":"Vigan\u00f2","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2026082412171373700_ciag114-B15","author":"American Society of Transplant Surgeons, The International Society for Health and Lung Transplantation","year":"2022"},{"key":"2026082412171373700_ciag114-B16"},{"key":"2026082412171373700_ciag114-B17","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/vaccines12121449","article-title":"Vaccination after haematopoietic stem cell transplant: a review of the literature and proposed vaccination protocol","volume":"12","author":"Silva-Pinto","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"2026082412171373700_ciag114-B18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jtct.2022.09.002","article-title":"Revised guidelines for coronavirus disease 19 management in hematopoietic cell transplantation and cellular therapy recipients (August 2022)","volume":"28","author":"Dioverti","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2026082412171373700_ciag114-B19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr.25045","article-title":"2022 American college of rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases","volume":"75","author":"Bass","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026082412171373700_ciag114-B20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/vaccines13030328","article-title":"Immunogenicity and safety of the bivalent respiratory syncytial virus prefusion F subunit vaccine in immunocompromised or renally impaired adults","volume":"13","author":"Almeida","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"2026082412171373700_ciag114-B21","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1200\/JCO.24.00032","article-title":"Vaccination of adults with cancer: ASCO guideline","volume":"42","author":"Kamboj","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026082412171373700_ciag114-B22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2352-4642(22)00315-7","article-title":"Lessons learnt from influenza vaccination in immunocompromised children undergoing treatment for cancer","volume":"7","author":"Furlong","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"2026082412171373700_ciag114-B23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/infdis\/jiae508","article-title":"Vaccines for use in special populations: immunocompromised hosts","volume":"231","author":"Ison","year":"2025","journal-title":"J Infect Dis"},{"key":"2026082412171373700_ciag114-B24","doi-asserted-by":"crossref","first-page":"1040.e11","DOI":"10.1016\/j.cmi.2015.07.014","article-title":"Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe","volume":"21","author":"P\u00e9rez-Romero","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2026082412171373700_ciag114-B25","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/bloodadvances.2021004629","article-title":"Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients","volume":"5","author":"Vijenthira","year":"2021","journal-title":"Blood Adv"},{"key":"2026082412171373700_ciag114-B26","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/21645515.2018.1445446","article-title":"Seasonal influenza vaccine in immunocompromised persons","volume":"14","author":"Bosaeed","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2026082412171373700_ciag114-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7305a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices\u2014united States, 2024\u201325 influenza season","volume":"73","author":"Grohskopf","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"2026082412171373700_ciag114-B28","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.1016\/j.vaccine.2020.11.037","article-title":"Influenza vaccination in immunocompromised populations: strategies to improve immunogenicity","volume":"39 Suppl 1","author":"Caldera","year":"2021","journal-title":"Vaccine"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag114\/67196079\/ciag114.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_3\/i105\/67196079\/ciag114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_3\/i105\/67196079\/ciag114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:17:19Z","timestamp":1787588239000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/Supplement_3\/i105\/8503202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":28,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2026,3,2]]},"published-print":{"date-parts":[[2026,8,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag114","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,15]]},"published":{"date-parts":[[2026,3,2]]}}}